Trial NCT03382912

View at ClinicalTrials.gov 
Org. Study IDs: 17161
Secondary IDs: AM0010-202 J1L-AM-JZGD

Last trial update was posted on 2020-09-11

MeSH Interventions

Nivolumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non Small Cell Lung Cancer

Stopping Reasons

The CYPRESS-2 trial was closed early after the planned final analysis because the risk benefit ratio is unfavorable.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID